Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease

Expert Opinion on Drug Metabolism and Toxicology

Volumn 7, Issue 10, 2011, Pages 1267-1293

  Ma, Qiang ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

AH receptor; AHR ligand; CYP1A1 induction; FICZ; Tryptophan photoreaction; UV response

Indexed keywords

1,3,8 TRICHLORO 6 METHYLDIBENZOFURAN; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 6 FORMYLINDOLO[3,2 B]CARBAZOLE; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; AROMATIC HYDROCARBON RECEPTOR; CYCLOOXYGENASE 2; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DRUG METABOLIZING ENZYME; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDIRUBIN; M 50367; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; RESVERATROL; RIBOSOME RNA; TAMOXIFEN; TRYPTAMINE; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG; VAF 347;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; BREAST TUMOR; CANCER INHIBITION; CELL MEMBRANE; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CIRCADIAN RHYTHM; CYTOPLASM; DENDRITIC CELL; DNA DAMAGE; DRUG METABOLISM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME METABOLISM; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENOTOXICITY; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; LIGHT; LYMPHOCYTE DIFFERENTIATION; MELANOGENESIS; NONHUMAN; OSCILLATION; PHOTOREACTIVITY; PNEUMONIA; PROTEIN EXPRESSION; RADIATION RESPONSE; REVIEW; RIBOSOME; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DISEASE; STEM CELL TRANSPLANTATION; SUN EXPOSURE; SUNLIGHT; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; ULTRAVIOLET RADIATION; UTERUS TUMOR;

ANIMALS; CARBAZOLES; CYTOCHROME P-450 CYP1A1; DNA DAMAGE; HUMANS; IMMUNOSUPPRESSION; LIGANDS; LIGHT; METABOLIC DETOXICATION, DRUG; NF-KAPPA B; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; SKIN; TRYPTOPHAN; ULTRAVIOLET RAYS;

MAMMALIA;

EID: 80053017405     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2011.614947     Document Type: Review

References (181)

1. Ma Q, Lu AYH. Drug metabolizing enzymes, a group of promiscuous proteins. In: Prakash C, Gan L, Zhong D. et al editors. Handbook of metabolic pathways of xenobiotics. John Wiley & Sons, New York; 2011; In press
2. Ma Q. Xenobiotic-activated receptors: from transcription to drug metabolism to disease. Chem Res Toxicol 2008;7:1651-71
3. Pascussi JM, Gerbal-Chaloin S, Duret C, et al. The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu Rev Pharmacol Toxicol 2008;48:1-32 (Pubitemid 351738147)
4. Burbach KM, Poland A, Bradfield CA. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA 1992;89:8185-9
5. Ma Q. Overview of AHR functional domains and the classical AHR signaling pathway: induction of drug-metabolizing enzymes. In: Pohjanvirta R. editor. The AH receptor in biology and toxicology. John Wiley & Sons, New York; 2011; In press
6. Conney AH, Miller EC, Miller JA. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res 1956;16:450-9
7. Ma Q, Lu AY. CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metab Dispos 2007;35:1009-16 (Pubitemid 46956419)
8. Poland A, Knutson JC. 2,3,7,8- tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 1982;22:517-54
9. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, et al. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p- dioxininduced toxicity. Toxicol Appl Pharmacol 1996;140:173-9 (Pubitemid 26329475)
10. White SS, Birnbaum LS. An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009;27:197-211
11. Whitlock JP Jr. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 1999;39:103-25 (Pubitemid 29222553)
12. Ma Q. Induction of CYP1A1. The AhR/ DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr Drug Metab 2001;2:149-64 (Pubitemid 32537000)
13. Perdew GH. Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem 1988;263:13802-5
14. Ma Q, Whitlock JP Jr. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 1997;272:8878-84 (Pubitemid 27154882)
15. Kazlauskas A, Poellinger L, Pongratz I. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J Biol Chem 1999;274:13519-24
16. Hoffman EC, Reyes H, Chu FF, et al. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991;252:954-8 (Pubitemid 21917012)
17. Denison MS, Fisher JM, Whitlock JP Jr. Inducible, receptor-dependent protein- DNA interactions at a dioxin-responsive transcriptional enhancer. Proc Natl Acad Sci USA 1988;85:2528-32
18. Ma Q, Baldwin KT. 2,3,7,8- tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activaton and DNA binding of AhR. J Biol Chem 2000;275:8432-8 (Pubitemid 30180187)
19. Ma Q, Renzelli AJ, Baldwin KT, et al. Superinduction of CYP1A1 gene expression. Regulation of 2,3,7, 8- tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide. J Biol Chem 2000;275:12676-83 (Pubitemid 30241418)
20. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003;43:309-34 (Pubitemid 37372644)
21. Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008;21:102-16 (Pubitemid 351219712)
22. Lahvis GP, Pyzalski RW, Glover E, et al. The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol Pharmacol 2005;67:714-20 (Pubitemid 40365318)
23. Zaher H, Fernandez-Salguero PM, Letterio J, et al. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Mol Pharmacol 1998;54:313-21 (Pubitemid 28368821)
24. Bock KW, Kohle C. The mammalian aryl hydrocarbon (Ah) receptor: from mediator of dioxin toxicity toward physiological functions in skin and liver. Biol Chem 2009;390:1225-35
25. Esser C, Rannug A, Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol 2009;30:447-54
26. Singh KP, Casado FL, Opanashuk LA, et al. The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem Pharmacol 2009;77:577-87
27. Ma Q, Whitlock JP Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 1996;16:2144-50 (Pubitemid 26123735)
28. Boitano AE, Wang J, Romeo R, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010;329:1345-8
29. Kim SH, Henry EC, Kim DK, et al. Novel compound 2-methyl-2H-pyrazole- 3-carboxylic acid (2-methyl-4-o-tolylazophenyl)- amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol 2006;69:1871-8 (Pubitemid 43894303)
30. Murray IA, Flaveny CA, DiNatale BC, et al. Antagonism of aryl hydrocarbon receptor signaling by 6,2,4-trimethoxyflavone. J Pharmacol Exp Ther 2010;332:135-44
31. Murray IA, Krishnegowda G, DiNatale BC, et al. Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties. Chem Res Toxicol 2010;23:955-66
32. Smith KJ, Murray IA, Tanos R, et al. Identification of a high affinity ligand that exhibits complete Ah receptor antagonism. J Pharmacol Exp Ther 2011;Fast Forward as; DOI:10.1124/ jpet.110.178392
33. Lawrence BP, Denison MS, Novak H, et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 2008;112:1158-65
34. Negishi T, Kato Y, Ooneda O, et al. Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/ TH2 balance. J Immunol 2005;175:7348-56 (Pubitemid 41713431)
35. Adachi J, Mori Y, Matsui S, et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 2001;276:31475-8
36. Bjeldanes LF, Kim JY, Grose KR, et al. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8- tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 1991;88:9543-7 (Pubitemid 21915667)
37. Song J, Clagett-Dame M, Peterson RE, et al. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci USA 2002;99:14694-9 (Pubitemid 35334546)
38. DiNatale BC, Murray IA, Schroeder JC, et al. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 2010;115:89-97
39. Mezrich JD, Fechner JH, Zhang X, et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 2010;185:3190-8
40. Nguyen NT, Kimura A, Nakahama T, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA 2010;107:19961-6
41. Rannug A, Fritsche E. The aryl hydrocarbon receptor and light. Biol Chem 2006;387:1149-57 (Pubitemid 44402061)
42. Rannug A, Rannug U, Rosenkranz HS, et al. Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J Biol Chem 1987;262:15422-7
43. Rannug U, Rannug A, Sjoberg U, et al. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol 1995;2:841-5
44. Wincent E, Amini N, Luecke S, et al. The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6- formylindolo[3,2-b]carbazole is present in humans. J Biol Chem 2009;284:2690-6
45. Heath-Pagliuso S, Rogers WJ, Tullis K, et al. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 1998;37:11508-15 (Pubitemid 28388192)
46. Nebert DW, Karp CL. Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J Biol Chem 2008;283:36061-5
47. Casper RF, Quesne M, Rogers IM, et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 1999;56:784-90 (Pubitemid 29491181)
48. Bittinger MA, Nguyen LP, Bradfield CA. Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor. Mol Pharmacol 2003;64:550-6 (Pubitemid 37048557)
49. Chowdhury G, Dostalek M, Hsu EL, et al. Structural identification of Diindole agonists of the aryl hydrocarbon receptor derived from degradation of indole-3-pyruvic acid. Chem Res Toxicol 2009;22:1905-12
50. Henry EC, Bemis JC, Henry O, et al. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch Biochem Biophys 2006;450:67-77 (Pubitemid 43782737)
51. Heath-Pagliuso S, Mui R, Milici A, et al. Tryptophan metabolites, indole-3-pyruvic acid, DL-3-indoleacetic acid, L-kynurenine and kynurenic acid activate Ah receptor signal transduction. Organohal Compd 2000;49:289-92
52. Nguyen LP, Hsu EL, Chowdhury G, et al. D-amino acid oxidase generates agonists of the aryl hydrocarbon receptor from D-tryptophan. Chem Res Toxicol 2009;22:1897-904
53. Wille G, Mayser P, Thoma W, et al. Malassezin-A novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur. Bioorg Med Chem 2001;9:955-60 (Pubitemid 32448116)
54. Fritsche E, Schafer C, Calles C, et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 2007;104:8851-6 (Pubitemid 47175400)
55. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003;4:649-61 (Pubitemid 37280160)
56. Green CB, Menaker M. Circadian rhythms. Clocks on the brain. Science 2003;301:319-20
57. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-88S
58. Agar N, Young AR. Melanogenesis: a photoprotective response to DNA damage? Mutat Res 2005;571:121-32 (Pubitemid 40313437)
59. Alvares AP, Kappas A, Levin W, et al. Inducibility of benzo(a)pyrene hydroxylase in human skin by polycylic hydrocarbons. Clin Pharmacol Ther 1973;14:30-40
60. Mukhtar H, DelTito BJ Jr, Matgouranis PM, et al. Additive effects of ultraviolet B and crude coal tar on cutaneous carcinogen metabolism: possible relevance to the tumorigenicity of the Goeckerman regimen. J Invest Dermatol 1986;87:348-53 (Pubitemid 16051175)
61. Katiyar SK, Matsui MS, Mukhtar H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J Invest Dermatol 2000;114:328-33 (Pubitemid 30417769)
62. Smith G, Ibbotson SH, Comrie MM, et al. Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. Br J Dermatol 2006;155:275-81 (Pubitemid 44050559)
63. Hildesheim J, Fornace AJ Jr. The dark side of light: the damaging effects of UV rays and the protective efforts of MAP kinase signaling in the epidermis. DNA Repair (Amst) 2004;3:567-80 (Pubitemid 38609047)
64. Rubin AI, Chen EH, Ratner D, et al. Basal-cell carcinoma. N Engl J Med 2005;353:2262-9 (Pubitemid 41697289)
65. Van Laethem A, Claerhout S, Garmyn M, et al. The sunburn cell: regulation of death and survival of the keratinocyte. Int J Biochem Cell Biol 2005;37:1547-53 (Pubitemid 40719633)
66. Trautinger F. Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin Exp Dermatol 2001;26:573-7 (Pubitemid 32989581)
67. NCI. Skin cancer. 2011.Available from: www.cancer.gov/ cancertopics/types/skin
68. Ullrich SE. Sunlight and skin cancer: lessons from the immune system. Mol Carcinog 2007;46:629-33 (Pubitemid 47255179)
69. Herrlich P, Karin M, Weiss C. Supreme EnLIGHTenment: damage recognition and signaling in the mammalian UV response. Mol Cell 2008;29:279-90 (Pubitemid 351215936)
70. Sakurai H, Yasui H, Yamada Y, et al. Detection of reactive oxygen species in the skin of live mice and rats exposed to UVA light: a research review on chemiluminescence and trials for UVA protection. Photochem Photobiol Sci 2005;4:715-20 (Pubitemid 41367022)
71. Black HS. Reassessment of a free radical theory of cancer with emphasis on ultraviolet carcinogenesis. Integr Cancer Ther 2004;3:279-93 (Pubitemid 39552422)
72. Ma Q. Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacol Ther 2010;125:376-93
73. Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res. 2005;571:3-17 (Pubitemid 40313428)
74. Jans J, Schul W, Sert YG, et al. Powerful skin cancer protection by a CPD-photolyase transgene. Curr Biol 2005;15:105-15
75. Pacek M, Walter JC. A requirement for MCM7 and Cdc45 in chromosome unwinding during eukaryotic DNA replication. EMBO J 2004;23:3667-76 (Pubitemid 39336288)
76. Hanawalt PC. Subpathways of nucleotide excision repair and their regulation. Oncogene 2002;21:8949-56 (Pubitemid 36110824)
77. Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003;300:1542-8 (Pubitemid 36682880)
78. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-23 (Pubitemid 39551659)
79. Carson CT, Schwartz RA, Stracker TH, et al. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J 2003;22:6610-20 (Pubitemid 38009607)
80. Devary Y, Rosette C, DiDonato JA, et al. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 1993;261:1442-5 (Pubitemid 23334264)
81. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006;7:833-46 (Pubitemid 44627477)
82. Gross S, Knebel A, Tenev T, et al. Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction. J Biol Chem 1999;274:26378-86
83. Salmeen A, Andersen JN, Myers MP, et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003;423:769-73 (Pubitemid 36735701)
84. Iordanov MS, Magun BE. Different mechanisms of c-Jun NH(2)-terminal kinase-1 (JNK1) activation by ultraviolet-B radiation and by oxidative stressors. J Biol Chem 1999;274:25801-6
85. Swanson HI. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem Biol Interact 2004;149:69-79 (Pubitemid 39387210)
86. Goerz G, Merk H, Bolsen K, et al. Influence of chronic UV-light exposure on hepatic and cutaneous monooxygenases. Experientia 1983;39:385-6 (Pubitemid 13122895)
87. Goerz G, Barnstorf W, Winnekendonk G, et al. Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes. Arch Dermatol Res 1996;289:46-51 (Pubitemid 27011067)
88. Plewka A, Czekaj P, Kaminski M, et al. Circadian changes of cytochrome P-450-dependent monooxygenase system in the rat liver. Pol J Pharmacol Pharm 1992;44(6):655-61 (Pubitemid 23135066)
89. Huang P, Ceccatelli S, Rannug A. A study on diurnal mRNA expression of CYP1A1, AHR, ARNT and PER2 in rat pituitary and liver. Environ Toxicol Pharmacol 2002;11:119-26 (Pubitemid 34142711)
90. Paigen B, Ward E, Reilly A, et al. Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes. Cancer Res 1981;41:2757-61 (Pubitemid 11071808)
91. Tuominen R, Warholm M, Moller L, et al. Constitutive CYP1B1 mRNA expression in human blood mononuclear cells in relation to gender, genotype, and environmental factors. Environ Res 2003;93:138-48 (Pubitemid 37083323)
92. Paine AJ. Induction of benzo[a]pyrene Mono-oxygenase in liver cell culture by the photochemical generation of active oxygen species. Evidence for the involvement of singlet oxygen and the formation of a stable inducing intermediate. Biochem J 1976;158:109-17
93. Wei YD, Rannug U, Rannug A. UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan. Chem Biol Interact 1999;118:127-40 (Pubitemid 29179538)
94. Kim BJ, Hwang DY, Kang TS, et al. Expression of human CYP1B1/lacZ fusion gene in ultraviolet-irradiated human keratinocytes. Arch Dermatol Res 2002;294:152-4 (Pubitemid 34591579)
95. Villard PH, Sampol E, Elkaim JL, et al. Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure. Toxicol Appl Pharmacol 2002;178:137-43 (Pubitemid 34214662)
96. Paine AJ, Francis JE. The induction of benzo[a]pyrene-3-mono-oxygenase by singlet oxygen in liver cell culture is mediated by oxidation products of histidine. Chem Biol Interact 1980;30:343-53 (Pubitemid 10111839)
97. Helferich WG, Denison MS. Ultraviolet photoproducts of tryptophan can act as dioxin agonists. Mol Pharmacol 1991;40:674-8
98. Oberg M, Bergander L, Hakansson H, et al. Identification of the tryptophan photoproduct 6-formylindolo[3,2-b] carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol Sci 2005;85:935-43 (Pubitemid 40846868)
99. Wei YD, Helleberg H, Rannug U, et al. Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole. Chem Biol Interact 1998;110:39-55 (Pubitemid 28157363)
100. Wei YD, Bergander L, Rannug U, et al. Regulation of CYP1A1 transcription via the metabolism of the tryptophan-derived 6-formylindolo[3,2-b]carbazole. Arch Biochem Biophys 2000;383:99-107
101. Bergander L, Wahlstrom N, Alsberg T, et al. Characterization of in vitro metabolites of the aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b] carbazole by liquid chromatography-mass spectrometry and NMR. Drug Metab Dispos 2003;31:233-41 (Pubitemid 36159616)
102. Bergander L, Wincent E, Rannug A, et al. Metabolic fate of the Ah receptor ligand 6-formylindolo[3,2-b]carbazole. Chem Biol Interact 2004;149:151-64 (Pubitemid 39402931)
103. Xu Y, Voorhees JJ, Fisher GJ. Epidermal growth factor receptor is a critical mediator of ultraviolet B irradiation-induced signal transduction in immortalized human keratinocyte HaCaT cells. Am J Pathol 2006;169:823-30 (Pubitemid 44411950)
104. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996;274:1194-7 (Pubitemid 26389285)
105. Kitagawa D, Tanemura S, Ohata S, et al. Activation of extracellular signal-regulated kinase by ultraviolet is mediated through Src-dependent epidermal growth factor receptor phosphorylation. Its implication in an anti-apoptotic function. J Biol Chem 2002;277:366-71 (Pubitemid 34952067)
106. Enan E, Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 1996;52:1599-612 (Pubitemid 26375466)
107. Agostinis P, Garmyn M, Van Laethem A. The Aryl hydrocarbon receptor: an illuminating effector of the UVB response. Sci STKE 2007;403:pe49
108. Dunlap JC. Molecular bases for c ircadian clocks. Cell 1999;96:271-90
109. Matsuo T, Yamaguchi S, Mitsui S, et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003;302:255-9 (Pubitemid 37248750)
110. Portaluppi F, Vergnani L, Manfredini R, et al. Endocrine mechanisms of blood pressure rhythms. Ann NY Acad Sci 1996;783:113-31 (Pubitemid 26372085)
111. Refinetti R, Menaker M. The circadian rhythm of body temperature. Physiol Behav 1992;51:613-37
112. Schlierf G, Dorow E. Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis. J Clin Invest 1973;52:732-40
113. Yamaguchi S, Isejima H, Matsuo T, et al. Synchronization of cellular clocks in the suprachiasmatic nucleus. Science 2003;302:1408-12 (Pubitemid 37452185)
114. Wager-Smith K, Kay SA. Circadian rhythm genetics: from flies to mice to humans. Nat Genet 2000;26:23-7
115. Gekakis N, Staknis D, Nguyen HB, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998;280:1564-9 (Pubitemid 28277694)
116. Shimba S, Watabe Y. Crosstalk between the AHR signaling pathway and circadian rhythm. Biochem Pharmacol 2009;77:560-5
117. Takahata S, Sogawa K, Kobayashi A, et al. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock. Biochem Biophys Res Commun 1998;248:789-94 (Pubitemid 28404501)
118. Yu W, Ikeda M, Abe H, et al. Characterization of three splice variants and genomic organization of the mouse BMAL1 gene. Biochem Biophys Res Commun 1999;260:760-7 (Pubitemid 29371124)
119. Hogenesch JB, Gu YZ, Jain S, et al. The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci USA 1998;95:5474-9 (Pubitemid 28224118)
120. Richardson VM, Santostefano MJ, Birnbaum LS. Daily cycle of bHLH-PAS proteins, Ah receptor and Arnt, in multiple tissues of female Sprague-Dawley rats. Biochem Biophys Res Commun 1998;252:225-31 (Pubitemid 28534655)
121. Mukai M, Lin TM, Peterson RE, et al. Behavioral rhythmicity of mice lacking AhR and attenuation of light-induced phase shift by 2,3,7,8- tetrachlorodibenzo-p-dioxin. J Biol Rhythms 2008;23:200-10 (Pubitemid 351652366)
122. Qu X, Metz RP, Porter WW, et al. Disruption of clock gene expression alters responses of the aryl hydrocarbon receptor signaling pathway in the mouse mammary gland. Mol Pharmacol 2007;72:1349-58 (Pubitemid 350012608)
123. Garrett RW, Gasiewicz TA. The aryl hydrocarbon receptor agonist 2,3,7,8- tetrachlorodibenzo-p-dioxin alters the circadian rhythms, quiescence, and expression of clock genes in murine hematopoietic stem and progenitor cells. Mol Pharmacol 2006;69:2076-83 (Pubitemid 43894327)
124. Mukai M, Tischkau SA. Effects of tryptophan photoproducts in the circadian timing system: searching for a physiological role for aryl hydrocarbon receptor. Toxicol Sci 2007;95:172-81 (Pubitemid 44942787)
125. Dunagin WG. Cutaneous signs of systemic toxicity due to dioxins and related chemicals. J Am Acad Dermatol 1984;10:688-700 (Pubitemid 14171249)
126. Masuda Y. Health status of Japanese and Taiwanese after exposure to contaminated rice oil. Environ Health Perspect 1985;60:321-5 (Pubitemid 15038916)
127. Kanagawa Y, Matsumoto S, Koike S, et al. Association of clinical findings in Yusho patients with serum concentrations of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran more than 30 years after the poisoning event. Environ Health 2008;7:47
128. Miller RW. Cola-colored babies. Chlorobiphenyl poisoning in Japan. Teratology 1971;4:211-12
129. Luecke S, Backlund M, Jux B, et al. The aryl hydrocarbon receptor (AHR), a novel regulator of human melanogenesis. Pigment Cell Melanoma Res 2010;23:828-33
130. Jux B, Kadow S, Luecke S, et al. The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning. J Invest Dermatol 2011;131:203-10
131. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol Cell Biol 2001;79:547-68 (Pubitemid 33070443)
132. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007;7:139-47 (Pubitemid 46160989)
133. Ma Q. Ah receptor: xenobiotic response meets inflammation. Blood 2008;112:928-9
134. Tauchi M, Hida A, Negishi T, et al. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol Cell Biol 2005;25:9360-8 (Pubitemid 41507837)
135. Kaufman CK, Fuchs E. Its got you covered. NF-kappaB in the epidermis. J Cell Biol 2000;149:999-1004 (Pubitemid 30354249)
136. Luecke S, Wincent E, Backlund M, et al. Cytochrome P450 1A1 gene regulation by UVB involves crosstalk between the aryl hydrocarbon receptor and nuclear factor kappaB. Chem Biol Interact 2010;184:466-73
137. Tian Y, Ke S, Denison MS, et al. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 1999;274:510-15 (Pubitemid 29035090)
138. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005;571:185-205 (Pubitemid 40313441)
139. Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974;53:1333-6
140. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008;453:65-71 (Pubitemid 351630328)
141. Quintana FJ, Murugaiyan G, Farez MF, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2010;107:20768-73
142. Veldhoen M, Hirota K, Christensen J, et al. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 2009;206:43-9
143. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008;453:106-9 (Pubitemid 351630329)
144. Zhang L, Ma J, Takeuchi M, et al. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci 2010;51:2109-17
145. Kerkvliet NI, Steppan LB, Vorachek W, et al. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. Immunotherapy 2009;1:539-47
146. Hauben E, Gregori S, Draghici E, et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008;112:1214-22
147. Apetoh L, Quintana FJ, Pot C, et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 2010;11:854-61
148. Gandhi R, Kumar D, Burns EJ, et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol 2010;11:846-53
149. Nair S, Kekatpure VD, Judson BL, et al. UVR exposure sensitizes keratinocytes to DNA adduct formation. Cancer Prev Res (Phila) 2009;2:895-902
150. Uno S, Dalton TP, Derkenne S, et al. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol 2004;65:1225-37 (Pubitemid 38543493)
151. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-60 (Pubitemid 44862679)
152. Brecher AR. The role of cyclooxygenase-2 in the pathogenesis of skin cancer. J Drugs Dermatol 2002;1:44-7
153. Fischer SM, Pavone A, Mikulec C, et al. Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol Carcinog 2007;46:363-71 (Pubitemid 46744456)
154. Akunda JK, Chun KS, Sessoms AR, et al. Cyclooxygenase-2 deficiency increases epidermal apoptosis and impairs recovery following acute UVB exposure. Mol Carcinog 2007;46:354-62 (Pubitemid 46744455)
155. Chun KS, Akunda JK, Langenbach R. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4. Cancer Res 2007;67:2015-21 (Pubitemid 46424218)
156. Safe S, McDougal A. Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers [review]. Int J Oncol 2002;20:1123-8
157. Kato Y, Manabe T, Tanaka Y, et al. Effect of an orally active Th1/ Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice. J Immunol 1999;162:7470-9 (Pubitemid 29277727)
158. Zeligs MA, Sepkovic DW, Manrique C, et al. Absorption-enhanced 3,3- diindolylmethane: human use in HPV-related, benign and pre-cancerous conditions. Proc Am Assoc Cancer Res 2002;43:3198
159. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-20 (Pubitemid 127696281)
160. Ciolino HP, Daschner PJ, Yeh GC. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 1998;58:5707-12 (Pubitemid 29006410)
161. Beedanagari SR, Bebenek I, Bui P, et al. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory region of the corresponding genes. Toxicol Sci 2009;110:61-7
162. Berge G, Ovrebo S, Botnen IV, et al. Resveratrol inhibits benzo(a)pyrene- DNA adduct formation in human bronchial epithelial cells. Br J Cancer 2004;91:333-8 (Pubitemid 39037080)
163. Lu F, Zahid M, Wang C, et al. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res (Phila) 2008;1:135-45
164. Chun YJ, Kim MY, Guengerich FP. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 1999;262:20-4 (Pubitemid 29412616)
165. Ciolino HP, Yeh GC. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999;56:760-7 (Pubitemid 29491178)
166. Frericks M, Meissner M, Esser C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol Appl Pharmacol 2007;220:320-32 (Pubitemid 46627841)
167. Singh KP, Wyman A, Casado FL, et al. Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. Carcinogenesis 2009;30:11-19
168. Okudaira N, Iijima K, Koyama T, et al. Induction of long interspersed nucleotide element-1 (L1) retrotransposition by 6- formylindolo[3,2-b]carbazole (FICZ), a tryptophan photoproduct. Proc Natl Acad Sci USA 2010;107:18487-92
169. Ramos KS. Unraveling genetic regulatory networks of mammalian retroelements. BMC Proc 2009;3(Suppl 2):S3
170. Reschly EJ, Ai N, Welsh WJ, et al. Ligand specificity and evolution of liver X receptors. J Steroid Biochem Mol Biol 2008;110:83-94
171. Rannug A. The tryptophan photoproduct 6-formylindolo[3,2-b]carbazole helps genes jump. Proc Natl Acad Sci USA 2010;107:18239-40
172. Abdelrahim M, Newman K, Vanderlaag K, et al. 3,3- diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006;27:717-28
173. Jinno A, Maruyama Y, Ishizuka M, et al. Induction of cytochrome P450-1A by the equine estrogen equilenin, a new endogenous aryl hydrocarbon receptor ligand. J Steroid Biochem Mol Biol 2006;98:48-55 (Pubitemid 43113244)
174. Sinal CJ, Bend JR. Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol Pharmacol 1997;52:590-9 (Pubitemid 27443980)
175. Ciolino HP, Daschner PJ, Yeh GC. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 1999;340(Pt 3):715-22 (Pubitemid 29312869)
176. Diaz D, Fabre I, Daujat M, et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 1990;99:737-47 (Pubitemid 20243366)
177. Le Ferrec E, Lagadic-Gossmann D, Rauch C, et al. Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent. J Biol Chem 2002;277:24780-7 (Pubitemid 34952010)
178. Sandoz C, Lesca P, Carpy A, et al. Effects of carbaryl and naphthalene on rat hepatic CYP1A1/2: potential binding to Ah receptor and 4S benzo(a)pyrenebinding protein. Int J Mol Med 1998;2:615-23
179. Wilhelmsson A, Whitelaw ML, Gustafsson JA, et al. Agonistic and antagonistic effects of alpha-naphthoflavone on dioxin receptor function. Role of the basic region helix-loop-helix dioxin receptor partner factor Arnt. J Biol Chem 1994;269:19028-33
180. Diani-Moore S, Ma Y, Labitzke E, et al. Discovery and biological characterization of 1-(1-H-indole-3-yl)-9H-pyrido[3,4-b] indole as an aryl hydrocarbon receptor activator generated by photoactivation of tryptophan by sunlight. Chem Biol Interact 2011;193:119-28
181. Diani-Moore S, Labitzke E, Brown R, et al. Sunlight generates multiple tryptophan photoproducts eliciting high efficacy CYP1A induction in chick hepatocytes and in vivo. Toxicol Sci 2006;90:96-110 (Pubitemid 43264730)